A phase 3, randomized, double-blind, placebo-controlled study of abiraterone acetate plus prednisone in asymptomatic or mildly symptomatic subjects with metastatic castration-resistant prostate cancer

Authors
Category Primary study
Year 2012
This article has no abstract
Epistemonikos ID: 889b2fe5b362f3c0dd50b99b082dd0f77620f1b8
First added on: Jan 06, 2014